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Abstract: Background: hydrogels prepared with natural inorganic excipients and spring waters are
commonly used in medical hydrology. Design of these clay-based formulations continues to be a
field scarcely addressed. Safety and wound healing properties of different fibrous nanoclay/spring
water hydrogels were addressed. Methods: in vitro biocompatibility, by means of MTT assay,
and wound healing properties were studied. Confocal Laser Scanning Microscopy was used to
study the morphology of fibroblasts during the wound healing process. Results: all the ingredients
demonstrated to be biocompatible towards fibroblasts. Particularly, the formulation of nanoclays
as hydrogels improved biocompatibility with respect to powder samples at the same concentration.
Spring waters and hydrogels were even able to promote in vitro fibroblasts motility and, therefore,
accelerate wound healing with respect to the control. Conclusion: fibrous nanoclay/spring water
hydrogels proved to be skin-biocompatible and to possess a high potential as wound healing
formulations. Moreover, these results open new prospects for these ingredients to be used in new
therapeutic or cosmetic formulations.
Keywords: sepiolite; palygorskite; spring water; hydrogel; fibroblast; biocompatibility;
wound healing
1. Introduction
Chronic wounds are a current health problem with devastating consequences for patients
and contribute to major costs to healthcare systems and societies. This type of wound results
from an impaired wound healing process and is usually characterized by prolonged or excessive
inflammation, persistent infections and inability of the dermal and/or epidermal cells to respond to
repair stimuli [1–3]. The USA total Medicare spending for all wound types has been estimated to
range from $28.1 to $96.8 billion. Diabetic foot ulcers (one of the main chronic wounds) accounted
for $6.1 to $18.7 billion [2], the main cost burden attributed to amputations [1]. The development
and implementation of new wound healing management strategies and healthcare products is,
therefore, imperative. In recent years, different technological strategies have been proposed, including
clays, metals, polymers and lipid-based systems among others, as reviewed by Bernal-Chávez et al.
and García-Villén et al. [4,5]. Particularly, clay-based dressings have been proven to be useful
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in wound healing [5–7]. Among the different clay-based formulations, those composed of a clay
suspended in mineral medicinal water, known as therapeutic muds, are widely used in clinical medical
hydrology [8–10]. The solid phase of these systems is frequently incorporated into spring water
to obtain a semisolid formulation known as “artificial thermal mud” [11–14]. Thermal muds have
demonstrated their clinical effectiveness against dermatological affections such as psoriasis [15–18],
atopic dermatitis, vitiligo [19,20], seborrheic dermatitis, fungal infections, eczema [18,21–23] and
acne [24]. These clinical effects have been traditionally associated with the liquid phase. Avène and
La Roche-Posay spring waters increase the fluidity of plasma membranes on cultured human skin
fibroblasts [25–28] and have been useful in the management of chronic inflammatory skin diseases.
La Roche-Posay spring water protected cultured human skin fibroblasts against lipid peroxidation
induced by ultraviolet A and B radiation [29]. Boron and manganese-rich thermal waters are used for
the treatment of ulcers and chronic wounds [30–34].
The influence of the thermal mud’s solid phase in the resulting clinical efficacy has not been studied
in depth. The inorganic solid phase of thermal muds is mainly composed of clay minerals [8,10,35–37].
The clay mineral presence in wound healing formulations is supported by their already demonstrated
biocompatibility with different types of skin cells [38–40]. The combination of clay minerals with
other ingredients, such as polymers, allows the formation of scaffolding materials. In these occasions,
clay minerals not only improved the mechanical strength and functionality of the polymers, but they
also acted as synergistic ingredients for wound healing [41–44]. Biocompatibility of clay minerals such
as halloysite, montmorillonite, palygorskite, sepiolite and imogolite have been widely studied [45–55].
Sasaki et al. reported that Mg2+ and Si4+ ions released by a synthetic Mg-rich smectite clay mineral
can promote collagen formation and angiogenesis on skin wounds [56].
Moreover, palygorskite (“attapulgite”) has been used as scaffolding material when included
in poly(lactic-co-glycolic acid) nanofibers, being crucial for mesenchymal cell adhesion and
proliferation [57]. Sepiolite and palygorksite inhibit lipid peroxidation and possess anti-inflammatory
properties by reducing neutrophil migration and edema [58,59]. Pharmaceutical grade palygorskite
(Pharmasorb® colloidal) did not only demonstrate to be biocompatible but also to protect fibroblasts
from carvacrol cytotoxicity [6].
As discussed, both spring waters and clay minerals have been separately studied as potential
wound healing ingredients. Synergistic effects would be expectable when both ingredients are
formulated as spring-water/clay hydrogels. The role of these systems in wound healing studies has
been scarcely addressed. The existing studies include a clinical study of diabetic gangrenous wounds
treated with volcanic deposits muds [60], black-mud Dead Sea effects in wounded mice [61] and
wound healing activity of emulsions prepared with a Brazilian clay [62].
With these premises, spring water hydrogels have been recently formulated and characterized,
including mineralogical and chemical composition as well as textural and thermal properties, as a first
step in the design of pharmaceutical-grade systems [63]. The second step would involve the study and
evaluation of their biocompatibility. In this regard, the simplest starting point would include in vitro
biocompatibility studies over skin cells like fibroblasts and in vitro wound healing studies.
Particularly, the in vitro biocompatibility and cell gap motility (wound healing) properties of
two selected Spanish medicinal waters (obtained from Graena and Alicún de las Torres thermal
stations), two clay minerals (palygorskite and sepiolite) and their corresponding hydrogels were
studied. Additionally, particle size distribution and zeta potential measures as well as cation exchange
capacities of the solid phases were carried out. In vitro wound healing tests were also evaluated by
analyzing fibroblast F-actin microfilament organization by means of phalloidin staining. To the best of
the authors’ knowledge, this is the first time that nanoclay/spring water mineral medicinal hydrogels
have been evaluated in terms of in vitro cytotoxicity and wound healing.
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2. Materials and Methods
2.1. Materials
Two pharmaceutical grade clays granted by TOLSA company (Madrid, Spain)—magnesium
aluminum silicate (PS9) and attapulgite (G30)—with mineralogical identification previously evaluated
(Table 1) were used [63].
Table 1. Fibrous clay (PS9 and G30) mineralogical composition (modified from [63]).
PS9 G30
Mineralogical Composition
Sepiolite 92% Palygorskite 58%
Muscovite 8% Quartz 26%
Fluorapatite 7%
Smectites and sepiolite 6%
Calcite/dolomite 3%
Two medicinal waters from Graena (GR) and Alicún De Las Torres (ALI) thermal stations were used.
Both spring sources are located in Granada (Andalusia, Spain) and are classified as hypothermal (ALI)
and hyperthermal (GR), both of them having a strong mineralization [64,65]. Their pH, conductivity
and elemental compositions have been determined in a previous study, and results are summarized in
Table 2.
Table 2. Medicinal water characteristics and elemental composition determined by means of ICP-OES
and ICP-MS (modified from [63]).
ALI GR
pH ± s.d. 7.90 ± 0.0472 8.02 ± 0.0823
Conductivity (µS/cm) ± s.d. 2251.5 ± 6.74537 2465.5 ± 8.89482
El
em
en
ta
lC
om
po
si
ti
on
Ca (mg/L) 348.00 460.00
Mg (mg/L) 109.0 88.00
Na (mg/L) 57.00 27.40
K (mg/L) 4.60 6.80
B (µg/L) 25.00 12.00
Ba (µg/L) 18.80 13.00
Cr (µg/L) 4.3 1
Zn (µg/L) 464.99 301.08
Mn (µg/L) <1 108.66
Li (µg/L) 244.2 65.00
Ni (µg/L) 9.4 5.20
Fe (µg/L) 6.00 21.00
Se (µg/L) 2.3 1.00
According to previous studies and characterizations [63], hydrogels were prepared mixing 10%
w/w of each clay mineral with the corresponding spring water, by means of a turbine high-speed
agitator (Silverson LT, Chesham, UK) at 8000 rpm for 10 min. The obtained hydrogels are summarized
in Table 3.
Table 3. Thermal muds tested, identification codes and composition.
Identification Code Composition
PS9ALI 10% w/w PS9, 90% w/w ALI
PS9GR 10% w/w PS9, 90% w/w GR
G30ALI 10% w/w G30, 90% w/w ALI
G30GR 10% w/w G30, 90% w/w GR
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2.2. Characterization of Inorganic Ingredients
2.2.1. Particle Size
Particle size distribution was determined by a Malvern Mastersizer 2000 LF granulometer (Malvern
InstrumentsTM). Measurements were performed in purified water after dispersing the solids by midst
sonication for 30 s. The amount of sample added in each experiment was determined by the real-time
laser obscuration degree indicated by “Mastersizer 2000” software. The optimal laser obscuration was
delimited between 10–20%. Three replicates were performed for each sample, and statistical particle
diameters (d10, d50, d90) were calculated together with the SPAN factor as an index of the amplitude of
particle size distribution calculated according to Equation (1).
SPAN =
d90−d10
d50
(1)
2.2.2. Cation Exchange Capacity
Cation exchange capacity (CEC) of PS9 and G30 was determined by dispersing 1 g of dry powder
in 25 mL of tetramethyl ammonium bromide (TMAB) aqueous solution (1 M). The resultant dispersions
were shaken in a Roller Mixer for 24 h and subsequently centrifuged (8000 rpm, 30 min) and filtered
(0.45 µm pore size, HAWP-Millipore filter). Three replicates were performed for each sample together
with two blanks of pure TMAB (1 M). The CEC determination is based on the exchange between
bromine (in the TMAB solution) and cations present in the clay. The main exchangeable cations released
from the clay mineral, once the Br exchanged, are K+, Na+, Mg2+ and Ca2+. Cations released, present
in the resultant solution, were determined by ICP-OES (Optima 8300 ICP-OES Spectrometer, Perkin
Elmer, Waltham, MA, USA), and CEC was calculated as the sum of exchangeable cations, expressed in
mEq/100 g of clay mineral.
2.2.3. Zeta Potential
Zeta-potential (ζ-potential) measurements determine the electrical potential difference between
the stationary layer of fluid surrounding the solid particles and the bulk (electric double layer).
Zeta potentials of different concentrations of PS9 and G30, suspended in Dulbecco’s modified
Eagle medium, supplemented with 10% fetal bovine serum, 200 IU/mL penicillin and 0.2 mg/mL
streptomycin, were also measured. Afterwards, ζ-potentials of the aforementioned suspensions
were determined by using an electrophoretic light scattering (ELS) Zetasizer Naso-ZTM (Malvern
Instruments, Worcestershire, UK). Samples were placed inside a folded capillary zeta potential cell
(DTS1061, Malvern Instruments). Three replicates were obtained for each sample, and analyses were
done at 25 ± 0.5 ◦C. During the analyses, 20 points were collected for each replicate and results
expressed in mV.
2.3. In Vitro Tests of Inorganic Ingredients, Spring Waters and Hydrogels
2.3.1. Biocompatibility Tests
Normal human dermal fibroblasts (NHDFs) from juvenile foreskin (PromoCell GmbH, Heidelberg,
Germany) were used. All cells were between the 10th and 13th passages. NHDFs were grown in
Dulbecco’s modified Eagle medium (DMEM, Sigma Aldrich®-Merck, Milan, Italy), supplemented
with 10% fetal bovine serum (FBS, Euroclone, Milan, Italy), 200 IU/mL penicillin and 0.2 mg/mL
streptomycin (PBI International, I), kept at 37 ◦C in a 5% CO2 atmosphere with 95% relative humidity
(RH). Fibroblasts were seeded in 96-well plates (area 0.34 cm2/well) at a density of 105 cells/cm2. Cells
were grown 24 h to obtain sub-confluence. Then, cell substrates were washed with saline solution,
and the cell substrates were put in contact with the samples. Biocompatibility of all samples was
assessed after 24 h contact between samples and NHDF cultures. Powdered PS9 and G30 clay minerals
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were used in concentrations of 1000, 500, 50 and 5 µg/mL. ALI and GR medicinal waters were used
in concentrations 0.25, 2.5, 25 and 50% v/v. Regarding PS9ALI, PS9GR, G30ALI and G30GR, cell
contact concentrations were prepared in order to have equal amounts of clay mineral with respect to
powdery samples, bearing in mind that hydrogels were prepared with 10% w/w of the corresponding
clay. Since the final amount of clay fibroblasts was put in contact with the same as in the experiments
with pristine clays, the same concentration codes (1000, 500, 50 and 5 µg/mL) were used. Briefly,
clay and hydrogel samples were dispersed in sterile Hanks’ Balanced Salt Solution (Sigma-Aldrich)
and mixed with Ultra-Turrax® (S 25N, -18G, IKA, Staufen, Germany) for 5 min, 150,000 rpm. These
initial suspensions were subsequently diluted in order to obtain samples having a concentration in the
range previously mentioned. Eight replicates were assessed for all samples and for the control (NHDF
cultures in pure DMEM phenol red).
After the 24 h contact, growth medium and samples were withdrawn from each well, and MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) test was performed. This test is
based on the activity of mitochondrial dehydrogenases of vital cells that convert MTT in formazan
crystals. DMEM phenol red-free and 50 µL of MTT dissolution were added in each well, the final
MTT concentration being 2.5 mg/mL. MTT-NHDF contact was maintained for 3 h before the whole
supernatant was withdrawn and substituted by 100 µL of dimethyl sulfoxide solution (DMSO,
Sigma-Aldrich®-Merck, Milan, Italy) to dissolve formazan purple salts. The absorbance was assayed
at 570 nm by means of an ELISA plate reader (Imark Absorbance Reader, Bio-rad, Hercules, CA, USA),
with a reference wavelength set at 655 nm. Cell viability was calculated as % ratio of the absorbance of
each sample and the absorbance of the cells kept in contact with the growth medium (control).
2.3.2. Cell Motility Assay for Wound Healing
The gap closure cell motility assay is based on the employment of a Petri µ-Dish35 mm, low (Ibidi,
Giardini, Italy) in which a silicone insert is enclosed. The insert comprises two chambers with a growth
area of 0.22 cm2 divided by a septum with a width of cell-free gap of 500 ± 50 µm. NHDFs were seeded
in each chamber at 105 cells/cm2 concentration and were grown until confluence in the same conditions
described in Section 2.3.1. After 24 h, fibroblasts reached confluence, and the silicone inserts were
subsequently removed with sterile tweezers, displaying two areas of cell substrates divided by the
500 µm (± 50) gap.
Cell substrates were washed with sterile phosphate buffer solution (PBS; 10% v/v) to eliminate
debris. Then, they were put in contact with a final volume of 700 µL of phenol red DMEM in which
samples were included at determined concentrations. These concentrations were selected according to
MTT results. Particularly, PS9, G30, PS9ALI, PS9GR, G30ALI and G30GR were used in concentration
B (50 µg/mL of clay mineral), and spring waters were used in 2.5% v/v concentrations. Cells kept in
contact with pure growth medium were used as control.
Microphotographs were taken at prefixed time intervals (0, 24, 48 h) to evaluate cell growth
inside the gap. Anoptical microscope (Leica, DMI3000-B model) equipped with LAS EZ software was
used (Leica microsystems, Wetzlar, Germany). In order to analyze results in a more objective way,
the full area of the wound healing space was photographed in all samples. Then, wound closure was
monitored by measuring the remaining gap with ImageJ software. The percentage of wound closure
was calculated according to Equation (2), where WS0 stands for “wound space at time 0” and WS24 is
“wound space after 24 h”, both of them measured as an area (µm2).
% Wound closed after 24 h = 100 −
WS24
(
µm2
)
·100
WS0(µm2)
(2)
2.4. Confocal Laser Scanning Microscopy
An additional sequence of wound healing experiments was stopped at 24 h of growth in order
to study the morphology of fibroblasts during the wound closure procedure. NDHFs were washed
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three times with PBS (10% v/v) and fixed with glutaraldehyde solution in PBS (3% v/v, 800 µL;
Sigma-Aldrich®-Merck, Milan, Italy). Contact with glutaraldehyde was maintained for 2 h (4–8 ◦C),
and all samples were protected from light. Three PBS washes were once again performed prior to
fibroblast permeabilization. Permeabilization was performed by adding Triton X-10 (0.1% w/v) for
10 min at room temperature. Triple PBS wash was again performed. Fluorescein isothiocyanate (FITC,
λex = 495 nm; λem = 513 nm)-labeled phalloidin (Phalloidin-FITC, Sigma-Aldrich) was used to mark
polymerized F-actin in the cytoplasm of NHDF (50 µg/mL, darkness, 40 min at room temperature).
The procedure was defined according to fabricant indications. After several PBS washings aiming to
eliminate unbound phalloidin-FITC, fibroblast nuclei staining was done. Blue fluorescence nucleic
acid stain 4′,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) was used. This molecule binds to
double-stranded DNA, thus labelling nuclei (λex = 485 nm; λem = 552 nm). Contact between DAPI
and cells was maintained for 10 min at room temperature in darkness. Finally, samples were washed
and preserved in PBS (10% v/v) to avoid dryness. Confocal Laser Scanning Microscopy (CLSM)
microphotographs were obtained by a Leica TCS SP2 (Leica Microsystems, Milan, Italy). Images were
processed with ImageJ software.
2.5. Statistical Analysis
The statistical differences were determined by means of non-parametric Mann–Whitney (Wilcoxon)
W test. In all cases, SPSS Statistic software was used, and differences were considered significant at
p-values ≤ 0.05. Only significant differences are reported.
3. Results and Discussion
3.1. Caracterization of Inorganic Ingredients
3.1.1. Particle Size
The granulometric distribution of PS9 and G30 is plotted in Figure 1. Both samples were unimodal
and, therefore, homogeneous. PS9 showed to be finer than G30 (Table 4), the latter one slightly
asymmetric. Calculated SPAN factors showed that the amplitude of particle size distribution for both
samples had no significant difference (Table 4).
Table 4. Statistical particle diameters, SPAN factor (average ± s.d.; n = 3) and main modes of PS9 and
G30 clay minerals.
PS9 G30
d10 (µm) 4.0 ± 0.07 4.8 ± 0.03
d50 (µm) 9.9 ± 0.15 20.2 ± 0.03
d90 (µm) 23.9 ± 0.2 49.3 ± 0.10
SPAN Factor 2.0 ± 0.02 2.2 ± 0.01
Main Mode (µm) 8.9 28.3
In terms of hydrogels, the finer the particles of the solid phase, the higher the stability of the
resultant semisolid system (no phase separation) and the better the textural properties (smoothness).
Mineralogical composition of G30 (Table 1) included 26% w/w of quartz. The presence of this mineral
could influence rheology and textural properties of hydrogels. Particularly, it infers an abrasive texture
to the preparation if quartz particle sizes are big. Particle sizes higher than 150 µm could be abrasive,
particularly when they have remarkable hardness, such in the case of quartz [66]. Despite the presence
of 26% of quartz mineral in G30, its particles were smaller than 100 µm (Figure 1), which means that
resultant hydrogels possessed smooth textures, which are crucial for the acceptance of the patients [67].
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3.1.2. Cation Exchange Capacity
The individual exchangeable elements and total CEC of PS9 and G30 are summarized in Table 5.
Total CEC values were inside the expected CEC limits for sepiolite (9.18 mEq/100 g) and palygorskite
(16.29 mEq/100 g) [68,69]. Sepiolite and palygorskite CEC are usually <25 mEq/100 g [70] with higher
values usually related to impurities [71–81]. The higher CEC showed by G30 with respect to PS9 could
be explained by the presence of 6% w/w of smectites and/or sepiolite in G30, as previously described.
Table 5. CEC results of PS9 and G30 (average mEq/100 g ± s.d.; n = 3).
mEq/100g PS9 G30
Na+ 0.70 ± 0.045 1.68 ± 0.071
K+ 0.33 ± 0.023 0.13 ± 0.032
Mg2+ 3.62 ± 0.341 7.61± 0.326
Ca2+ 4.53 ± 0.123 6.87± 0.186
Total 9.18 16.29
The main exchangeable cations for both clays were Mg2+ and Ca2+, which was in agreement with
the chemical composition of PS9 and G30 showed by X-ray fluorescence analysis [63], though Na+ and
K+ were also detected in small amounts. Na+, K+, Mg2+ and Ca2+ are essential elements since they are
widely found inside and outside human cells [82–84]. The presence of suitable levels of ions such as
calcium, magnesium, sodium and potassium in the wound bed are important to enhance the healing
process. They allow the activity of the enzymes involved in the healing process, leading to the cascade
of the repairing and regenerative processes. Specifically, calcium and magnesium levels should raise
during the first 5 d of wound healing in order to promote granulation tissue formation and epidermal
cell proliferation [85]. Moreover, during the restoration of the trans-epithelial potential of cells in the
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damaged tissue, Na+, K+ and/or Ca2+ play a crucial role [86]. The bioavailability of these cations in the
wound site should promote the healing process and contribute to fasten the damaged area reparation.
Mg2+ cations, abundant in both ALI and GR, have demonstrated remarkable properties for
tissue regeneration and repair, particularly in the promotion of collagen formation and angiogenesis
on skin wounds [56,87]. For this reason, it is conceivable that ALI and GR should perform wound
healing effects, as previously remarked. The maximum exchangeable amount of Mg2+ from PS9
and G30 corresponded to 17.67 and 37.14 mg/L, respectively (Table 5). Magnesium concentration
due to the spring water was 5–12 mg/L, and this proved to be effective during wound healing by
Sasaki et al. [56]. Consequently, both PS9 and G30 were considered as potentially effective minerals
due to their exchangeable Mg2+ content.
Normal homeostasis of mammalian skin is also maintained by elements such as calcium,
modulating keratinocyte and fibroblast proliferation and differentiation [88]. Certain skin disorders,
such as psoriasis, have been related to Ca2+ disorders in keratinocytes [89,90]. Extracellular calcium
is a determinant factor in the differentiation and maturation of fibroblasts, and its effectiveness is
dose-dependent [89] Another recent study on wound healing demonstrated that calcium cations released
from a calcium alginate wound dressing promoted endothelial cell growth and proliferation [91].
Zinc is also important during wound healing steps [85,88], though it was not detected as an
exchangeable cation of PS9 nor G30 through the ICP-OES measurements performed. However, both
ALI and GR waters contained Zn (Table 2).
Potassium has also demonstrated to favor wound healing (fibroblast differentiation, re-epithelialization,
migration and proliferation of dermal cells), so its presence both in spring waters and hydrogels is considered
as a positive feature [92,93].
3.1.3. Zeta Potential
Zeta-potential results of PS9 and G30 at different concentrations are presented in Figure 2.
Regarding ζ potential of minerals in pH 7 buffer, PS9 and G30 results were in agreement with other
sepiolite and palygorskite samples previously studied [94–96]. In particular, the zeta potential of PS9
in aqueous pH 7 solution was more negative (higher) than that of G30.
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Negatively charged particles have also proved to interact with cells up to a certain extent and even
be able to enter by endocytosis-mediated mechanisms [102,103], although this happens with higher
difficulty for negative particles than for positive ones. The uncontrolled entrance of certain substances
into the cells could jeopardize their viability, thus inferring that positively charged materials are more
likely to put the cell viability at risk.
Another factor by which nanoparticle surface charge demonstrated to influence cell viability
is due to their agglomeration state [99]. Berg and co-workers revealed that hepatocytes showed
less viability when exposed to metal nanoparticles with zeta potentials close to their isoelectric
point [97]. This change in zeta potential was also strongly related to the agglomeration state of the
very same particles. That is, the more neutral the nanoparticles are, the more easily they aggregate
and, subsequently, the faster their precipitation over the cell tapestry and/or their interaction with the
negatively charged cell membranes.
Cell media, such as DMEM, have demonstrated to significantly modify zeta potential of different
suspended particles [104–106]. These changes are ascribed to the presence of a wide variety of charged
molecules such as amino acids and vitamins, among others. The interaction of clay particles with these
molecules changes the zeta potential of the former ones. In fact, PS9 and G30 suffered a significant
change of zeta potential when added to full DMEM culture medium (Figure 2). In this occasion,
no significant differences were found between PS9 and G30 values, thus confirming that the resultant
surface charges of the particles is governed by the culture medium. Therefore, during biocompatibility
and wound healing tests, clay particles should maintain a −10 mV zeta potential. The reduction of zeta
potential strength would reduce the stability of the clay suspensions, making them less flocculated and,
consequently, more prone to precipitation phenomena. Precipitation of clay particles could hinder cell
viability by cell suffocation. Nonetheless, the fact that they still showed a negative surface charge would
hinder the entrance of clay particles inside cells. These results will be confirmed by MTT analysis.
3.2. In Vitro Tests of Inorganic Ingredients, Spring Waters and Hydrogels
3.2.1. Biocompatibility Tests
Biocompatibility results on NHDF treated with medicinal ALI and GR waters for 24 h are plotted
in Figure 3. No significant differences were found, even when multiple comparisons were performed.
In fact, ALI and GR viability results were around 100% for all water dilutions. Therefore, mineral
medicinal waters studied in this work did not hinder dermal fibroblasts viability, thus determining
their biocompatibility. Internal comparisons between ALI and GR concentrations were also performed.
Mann–Whitney marked differences in ALI viability were between 50% vs. 0.25% and 25% vs. 0.25%
(Figure 3). Su et al. detected an optimal dilution of a concentrated underground mineral spring water
that made skin cells to grow better in comparison with other dilutions [107]. By the same token, ALI
concentrations higher than 25% (v/v) could allow slightly better NHDF growth performances with
respect to more diluted samples.
PS9 clay mineral and corresponding peloids PS9ALI and PS9GR are plotted in Figure 4 (left) as well
as G30 and its corresponding peloids G30ALI and G30GR Figure 4 (right). In a general view, the lower
the sample concentration (either clay or thermal mud), the higher the cell viability. None of the samples
nor their concentrations presented a cellular viability below 80%. This fact indicated the absence of
drastic cellular cytotoxicity within 24 h. With respect to PS9 and G30 clays, it was possible to observe a
slight reduction of the cellular viability (with respect to GM) as the clay concentration increased. In fact,
when the clay mineral concentration corresponded to 1 mg/mL, cellular viability was close to 80%
(for both pristine clays and thermal muds). Nonetheless, statistical analyses indicated no significant
differences between PS9 and G30 1000 µg/mL concentrations vs. GM, which confirmed that PS9 and
G30 were highly biocompatible against NHDF cells. G30 5 µg/mL concentration showed significant
differences vs. GM. Notably, the lower the concentration of the clay, the better the cellular proliferation.
It has been suggested by some studies that the precipitation of clay minerals could hinder cell viability
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by some sort of physical effect [50,103]. The biocompatibility of Veegum HS© (Bentonite clay) was
evaluated by Salcedo et al., finding that at 167 µg/mL of Veegum HS© concentration the viability of
Caco-2 cells reduced approximately to 50% [50]. This effect was ascribed to the precipitation of clay
particles, which blocked cell membrane channels. According to the authors, montmorillonite had a
particle size ranging from 45–75 µm [50], which is a particle size range very similar to that of PS9 and
G30. In these conditions, it was argued that if the precipitation of clay particles occurred, cell viability
could be compromised at concentrations ≥160 µg/mL. On the contrary, neither PS9 nor G30 showed
fibroblasts viabilities lower than 50% even at the highest concentration tested, thus demonstrating to
possess a remarkable biocompatibility.
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medium” and refers to control test. Mean values ± s.d.; n = 8. Significant differences were reported
within the figure (down) as “sig” which refers to “p-values”.
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Internal statistical studies for PS9 and G30 results detected significant differences in G30 1000µg/mL
vs. 50 µg/mL and 5 µg/mL. For PS9, concentrations of PS9 1000 and 500 µg/mL differed both between
them as well as with 50 and 5 µg/mL (see Figure 4). These findings mean that, for both clays,
smaller clay amounts in contact with fibroblasts were characterized by a higher degree of fibroblast
biocompatibility. The biocompatibility results obtained for both clays were in agreement with the
existing literature. Sepiolite clay mineral (Pangel S9) has been previously tested by Fukushima et al.
towards fibroblasts and osteoblasts [108]. In this case, authors combined 10% of sepiolite with
poly(butylene adipate-co-terephthalate) reporting no cytotoxicity. A Tolsa’s Group sepiolite clay
was also employed by Fernandes et al. [109]. In this case, they reported a reduction of HeLa cell
viability of 50% when sepiolite was present in 1000 µg/mL concentration. No such a reduction was
found in this work when PS9 was used at the same concentration. Nonetheless, these differences
could be ascribed to differences in the type of cell culture [110]. Apart from anti-inflammatory,
antibacterial and anti-oxidant properties of a natural Spanish palygorskite, its cytotoxicity against
murine macrophages has been reported to start from 300 µg/mL onwards [58,59]. Particularly, authors
reported a reduction of 20% viability at the aforementioned concentration. Once again, in the present
study, G30 showed higher biocompatibility (at least against fibroblasts) because, even at 500 µg/mL
concentration, fibroblasts did not show a viability reduction. In more recent studies, pharmaceutical
grade palygorskite (Pharmasorb® colloidal) was able to protect human dermal fibroblasts against
carvacrol cytotoxicity at clay concentrations ranging from 8 to 12 µg/mL [6].
Neither PS9ALI nor PS9GR showed significant differences between GM and tested concentrations,
thus demonstrating the total biocompatibility of these hydrogels. Statistically, PS9ALI and PS9GR
thermal mud showed similar significant differences between concentrations, following the same trend
previously described for PS9. In fact, 50 and 5 µg/mL clay concentrations apparently favored cellular
viability (Figure 4, left). The agreement among PS9ALI, PS9GR and PS9 biocompatibility results
allowed the confirmation of their reproducibility. Both PS9ALI and PS9GR, as well as PS9, shared
significant differences of concentration 50 µg/mL due to the higher viability results obtained at this
concentration (Figure 4, left).
Regarding G30ALI and G30GR peloids, Mann–Whitney statistical analysis pointed out significant
discrepancy in activity between G30ALI GM and 1000 µg/mL concentration vs. 5 µg/mL and between
G30GR 1000 µg/mL vs. 50 µg/mL (as specified in Figure 4, right). Since the same trend has been
reported for G30 samples, once again it was possible to confirm the reproducibility of the results.
Despite the complexity generated by the statistical analysis, all solid samples (Figure 4) showed a
better result for 50 µg/mL concentration, always with cellular viabilities higher than 100%. According
to these findings, 50 µg/mL clay concentration was the safest/most ideal one for fibroblast cultures,
regardless of the type (PS9 or G30) or the origin of the clay (powder or thermal mud). It is also important
not to forget the fact that all the tested concentrations were biocompatible for fibroblasts within 24 h
of contact. Due to the conclusions reached with the MTT test, 50 µg/mL was the clay concentration
selected for further studies including cell motility assay (wound healing) and proliferation CLSM tests.
For spring waters, 50% v/v concentration was used.
3.2.2. Cell Motility Assay for Wound Healing
Microscopy images of gap closure results are reported in Figures 5–7. ALI and GR samples
were tested at 50% (v/v) concentration, while PS9, G30, PS9ALI, PS9GR, G30ALI and G30GR were
tested at 50 µg/mL of clay mineral. The microphotographs taken at zero time (0 h) showed for all the
samples the presence of defined gaps mimicking wounds. Normal fibroblasts grown at confluence
were clearly visible in each side of the wound. The time 0 gaps were reported to measure approximately
500 µm, which was in agreement with the variability of the silicone inserts of the Petri µ-Dishes
used (500 ± 50 µm). Insoluble clay particles were visible in the cultures treated with PS9, G30 and
hydrogels PS9ALI, PS9GR, G30ALI and G30GR, unlike GM, ALI and GR. In all cases, after 24 h,
fibroblasts started to invade the gap and even established contact with the cells of the opposite side
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in certain points of some samples. NHDF cells also maintained their typical fusiform morphology
during the whole experiment. These facts confirmed that the presence of spring waters, clay or
hydrogels did not impair cell growth. This was in line with the biocompatibility results previously
discussed. In all cases, fibroblasts crossed the empty zone after 48 h, thus forming anastomosis.
In spring water ALI and GR samples, fibroblasts of both sides of the wound established contact within
24 h (Figure 5). In comparison with the control (GM), it was clear that the addition of ALI and GR
favored wound closure, since the contact points between fibroblasts were more numerous. According
to the measurements of the wounded area performed by image analysis, ALI and GR samples covered,
respectively, 62.9% and 59.1% of the initial wounded area, whereas GM covered about 31.8% of the
wound (Figure 8). After 48 h all the cell substrates reached confluence, and this further supports the
biocompatibility of the hydrogels and their components in vitro. Previous works have claimed that the
presence of elements such as B3+ and Mn+2 in keratinocyte culture mediums induced the migration
of these cells [30]. They tested boron and manganese at different concentrations (500–1000 µg/L and
100–1500 µg/L, respectively). In fact, keratinocytes in contact with these elements were able to cover
the artificial gap (scratch-assay method) with 20% more efficiency with respect to the control group
(without B3+ and Mn+2) in 24 h. ALI and GR chemical compositions have been previously reported by
Aguzzi et al. [111] and García-Villén et al. [63] (Table 3). The absence of significant differences between
GR, ALI and GM groups further confirmed the biocompatibility of both mineral medicinal waters
since they did not hinder wound closure. The presence of B3+ and Mn+2 in both GR and ALI could
explain why they did not interfere with cell motility during wound healing in a significant manner.
Other elements such as As3+ and Fe2+ (both presents in ALI and GR waters) have also demonstrated to
improve wound healing, particularly of the nasal mucosa [112]. General skin regenerative properties of
spring waters have been reported in the literature [32–34,113]. The study of Liang et al. demonstrated
that skin regenerative properties of Nagano spring water were related to the spring water chemical
composition, with no influence of microorganisms [31]. Another beneficial effect that could be ascribed
to ALI and GR according to their chemical composition is the protective effect against oxidative stress
due to the presence of sulfur [114].
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during the wound healing assay, slowi g down the total gap closur with respect to GM an studied
peloids. In fact, the uncovere gap width after 24 h was significantly higher for PS9 and G30 with
respect to t rest of the samples (Figure 8), thus indicating a slower coverage of the w unded
area. For these similar samples, the majority of insoluble particles visible within the cell substrate
were concentrated adjac nt to or over/in ide fibroblasts. I is well known that cell membranes are
negatively charged and can be penetrated by positive substances. Negatively charged particles ca
also intera t and even penetrate c lls by endocytosis-mediated mechanisms [102,103,115]. According
to the zeta p tential results previously reported (Figure 2), PS9 and G30 had a negative net charg
in the major part of the pH range tested. These clay particles could interact between them (thus
forming bigger aggregates) and with cells by establishing interactions such as Van der Waals forces.
This hypothesis was the starting point of Abduljauwad and Ahmed, who proposed that the interaction
between clay minerals and cells would hinder cell migration [116]. They evaluated the roles of
montmorillonite, hectorite and palygorskite particles in cancer cell migration and demonstrated these
materials could prevent cellular metastasis. Results of scratch-induced wound healing assays reported
by these authors demonstrated that clay mineral particles significantly delayed the gap closure in
comparison with control experiments. For instance, while the control showed full gap closure within
24 h, palygorskite showed a mean gap closure of 59 ± 3% after 24 h. Polymeric composite films
containing montmorillonite were evaluated by Salcedo et al. [50] and Mishra et al. [117]. The scratch
assay showed, in both cases, that the presence of montmorillonite particles alone was able to alter cell
behavior (Caco-2 and fibroblasts, respectively for each study), slowing down the gap closure. Similar
results were reported by Vaiana et al. on montmorillonite and keratinocytes [118]. These results were
in agreement with PS9 and G30 performances during wound healing: though clays were not cytotoxic,
more time would be necessary to obtain complete cell confluence within the artificial wound (gap) in
their presence. The biocompatibility and safety of natural clay minerals such as palygorskite during
wound healing was also supported by in vivo studies. A natural Brazilian palygorskite was tested for
in vivo wound healing of rats [119]. In comparison with functionalized clay minerals, the natural one
provided more advanced and safer wound healing, since histological cuts demonstrated the presence
of dermal papilla and hair follicles after 14 d of treatment [119].
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The presence of hydrogels promoted in vitro fibroblast mobility during wound healing processes.
In fact, coverage of the artificial gap was faster for PS9ALI, PS9GR, G30ALI and G30GR with respect
to GM and pristine clays (Figure 8). It is worth to note that all therapeutic muds were used in
concentrations equal to the powdered clay samples. That is, the amount of peloid within the culture
medium was higher in order to compensate for them only possessing a 10% w/w of clay mineral.
Whatsoever the nature of the interaction between clay particles and fibroblasts, responsible for the gap
closure deceleration (observed in PS9 and G30 tests), it was reduced to a minimum when it came to
thermal mud formulations. In fact, significant differences were found between gap closures of peloids
vs. GM, demonstrating that the evaluated hydrogels induced a positive effect during wound healing.
These results are supported by previous studies in which clay minerals have reported to
exert neutral or positive wound healing effects when combined with other substances [44,120].
For instance, no significant changes have been found during in vitro wound healing studies of
montmorillonite–chitosan–silver sulfadiazine nanocomposites with respect to the control. That is,
the presence of the clay mineral did not hinder the gap closure procedure and did not affect fibroblast
phenotypes [54]. On the other hand, better skin re-epithelialization and reorganization have been
found when halloysite and chitosan were combined to form a nanocomposite with respect to the use
of both materials independently [47]. In vivo infected wound treatment with silver nanoparticles
was improved by the use of montmorillonite as a carrier, which reduced the drug cytotoxicity [121].
Montmorillonite also demonstrated to exert a wound healing effect when combined with chitosan
and polyvinylpyrrolidone polymers [48]. The nanocomposite films containing bentonite increased the
in vivo wound healing processes in mice when compared with the formulations without the clay. For
instance, wound closure after 16 d was 92–93% for samples without clay and 95–97% for those with
montomorillonite, and all of them were higher than the negative control at the same time (84%) [48].
Despite the scarce literature regarding the use of therapeutic muds in skin regenerative properties,
the existing studies were also in agreement with the present observations. Thermal mud treatments
with volcanic deposits of Azerbaijan facilitated the healing of chronic gangrenous wounds of diabetic
patients [60]. The major part of the patients subjected to pelotherapy reached total wound recovery by
the end of the treatment. Two natural Dead Sea black mud samples were evaluated by Abu-al-Basal
for their in vivo wound healing properties [61]. One of them was used in its pristine state, while the
other was formulated in form of a facial mask by adding plant extracts and vitamin E. Both samples
accelerated the wound healing process by enhancing granulation, wound contraction, epithelialization,
angiogenesis and collagen deposition. Another in vivo wound healing study was performed by
Dário et al. [62]. They evaluated a natural peloid extracted from Ocara Lake (northeast of Brazil),
which was sieved, solid-state characterized and sterilized. The solid fraction was mainly composed of
quartz, illite and kaolinite, and it was formulated as an emulsion. The emulsion was put in contact
with injured Wistar rats. The formulation including the Ocara Lake solid fraction induced histological
changes in the deep dermis that allowed an effective healing with respect to control groups. On the other
hand, there is evidence in literature about the anti-inflammatory properties of peloids [122]. Moreover, a
recent study focusing on fibrous clays suggests that sepiolite and palygorskite, the main components of
PS9 and G30, respectively, did not influence the in vitro NO (inflammation signal) production of murine
macrophages (RAW 264.7). Furthermore, both clays decreased the leucocyte infiltration shortly after
exposure in vivo on mouse ear edema (12-O-tetradecanoylphorbol-13-acetate (TPA) as inflammatory
agent). In particular, sepiolite and palygorskite caused decreases on the number of infiltrated
cells per field [59]. Analogously, other clay minerals, as halloysite and montmorillonite, proved
macrophage cytocompatibility and negligible secretion of TNFa, as proinflammatory cytokines [123].
The anti-inflammatory properties of clays could control the inflammatory phase in the healing process,
shortening healing time and avoiding wound chronicity.
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3.3. Confocal Laser Scanning Microscopy
CLSM microphotograph results (Figure 9) showed fluorescence of fibroblast nuclei and cytoplasm.
Green fluorescence is due to the binding of phalloidin specifically with F-actin, and the blue one is
due to 4’,6-diamidino-2-phenylindole (DAPI) bounded to DNA. Morphology of fibroblasts during
wound healing is very important, since it gives information about migration and adhesion of cells.
F-actin filaments facilitate cell–cell interaction and tissue regeneration [124]. In all samples, regardless
of the type of sample with which fibroblasts were put in contact with, NHDF showed typical fusiform
morphology. Moreover, fibroblasts located in the wounded area possessed typical morphology of
migrating cells. Therefore, it was possible to identify retraction/protrusion parts of fibroblasts due to
the position of F-actin. Typical actin filament structures were detectable in all samples: lamellipodia,
filopodia and stress fibers (dorsal stress fibers and transverse arcs). Moreover, fibroblasts in mitosis
were also visible in some points.
Regarding the speed of wound closure, the CLSM results were in agreement with those obtained
by optical microscopy. GM control after 24 h demonstrated that NHDFs were able to make contact
and started to close the gap, though yet some empty zones were clearly visible. The number of cells
inside the wound gap in ALI and GR samples was higher than that in GM. PS9 and G30 showed
the worst result in terms of “gap closure”, which confirmed the previous results. Once again, it was
possible to observe that the “slowing down” effect of PS9 and G30 did not happen when both clays
were formulated in form of nanoclay/spring water hydrogels. Particularly, hydrogels G30ALI, G30GR,
PS9ALI and PS9GR induced a faster wound healing with respect to the rest of the samples.Pharmaceutics 2020, 12, x FOR PEER REVIEW 16 of 23 
 
 
Figure 9. CLSM microphotographs during wound healing. NHDMs were stained with phalloidin-
FITC (green, F-actin filaments) and DAPI (blue, nucleus). Green arrows indicate the migration 
direction; different F-actin structures have been identified by L (lamellipodia), F (filopodia), SF (stress 
fibers) and DSF (dorsal stress fibers). Additionally, M stands for (mitosis) and CP stands for (clay 
particles). 
Figure 9. Cont.
Pharmaceutics 2020, 12, 467 17 of 24
Pharmaceutics 2020, 12, x FOR PEER REVIEW 16 of 23 
 
 
Figure 9. CLSM microphotographs during wound healing. NHDMs were stained with phalloidin-
FITC (green, F-actin filaments) and DAPI (blue, nucleus). Green arrows indicate the migration 
direction; different F-actin structures have been identified by L (lamellipodia), F (filopodia), SF (stress 
fibers) and DSF (dorsal stress fibers). Additionally, M stands for (mitosis) and CP stands for (clay 
particles). 
Figure 9. CLSM microphotographs during wound healing. NHDMs were stained with phalloidin-FITC
(green, F-actin filaments) and DAPI (blue, nucleus). Green arrows indicate the migration direction;
different F-actin structures have been identified by L (lamellipodia), F (filopodia), SF (stress fibers) and
DSF (dorsal stress fibers). Additionally, M stands for (mitosis) and CP stands for (clay particles).
4. Conclusions
Fibroblast biocompatibility and wound healing efficacy of inorganic hydrogels formulated with
two nanoclays in two natural spring waters have been studied. Both spring waters were fully
biocompatible and favored wound healing, inducing faster gap closure with respect to control.
The studied nanoclays did not interfere with cell viability to a great extent (≥80% of cell viability), thus
not being cytotoxic at the studied concentrations. Nonetheless, they interfered with the in vitro wound
healing processes, slightly delaying gap closure when used as powders. This effect could be ascribed
to the presence of non-flocculated nanoclay particles in the culture medium. Hydrogels formulated
with the aforementioned ingredients did not hindered gap closure and reported a higher percentage of
wound closure after 24 h with respect to the control.
In conclusion, this study has demonstrated the usefulness and potential of PS9 and G30
clay minerals as excipients in the preparation of hydrogels intended for wound healing and other
therapeutic uses. Maximum in vitro wound healing effects were achieved by using PS9 in the
formulation of the hydrogels. These promising results encourage the use of clay minerals as wound
healing ingredients. Thermal center treatments are mostly focused on the physical effects of thermal
muds, which are very effective against musculoskeletal disorders. Nonetheless, the findings of this
study have opened new perspectives, since the addressed nanoclay/spring water hydrogels could also
be used to treat chronic wounds.
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